ACADIA PHARMACEUTICALS INC
Government Contracts & Awards
No recent government contracts or awards found.
Proprietary Tech & Patents
No patents found in our USPTO sample (a narrow, keyword-clustered feed of recent grants in strategic tech sectors — not a comprehensive patent database).
Form D Funding
No recent SEC Form D filings found.
Market Intelligence & News
3 Medical Stocks Standing Out After Crushing Q2 Earnings Expectations
As investors look to balance growth opportunities with defensive positioning, Acadia Pharmaceuticals, CVS Health, and Eli Lilly stand out as healthcare names combining resilient business models with strong earnings momentum.
The Zacks Analyst Blog Highlights Harmony Biosciences, Acadia Pharmaceuticals, Biogen, Insmed and Agios Pharmaceuticals
HRMY, ACAD, BIIB, INSM and AGIO are set to report Q2 results, with positive Earnings ESPs suggesting potential earnings surprises.
Congressional Trades in $ACAD
No disclosed congressional trades found in $ACAD.
Insider Trades (Form 4)
Schneyer Mark C.
Thompson Elizabeth H.Z.
Kihara James
Key People
Schneyer Mark C
EVP, CHIEF FINANCIAL OFFICER
Thompson Elizabeth H Z
EVP, Head of Research & Dev
Thompson Elizabeth H Z
EVP, Head of Research & Dev
Kihara James
PRINCIPAL ACCOUNTING OFFICER
Political Giving
No disclosed PAC contributions found for this entity.
Factual Connections
Connections to other companies, executives, and politicians — sourced from disclosed trades, shared officers/directors, and public filings — are a Pro/Alpha feature.
Upgrade to Pro